The Lung Research Center, LLC | ClinicalTrials HQ

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease	idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder	Enrolling by invitation	Phase 3	2026-10-06		NCT04905693
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis	bronchial disorder, bronchiectasis, respiratory system disorder	Recruiting	Phase 3	2026-10-01		NCT06872892
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast	idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder	Active, not recruiting	Phase 3	2026-09-30		NCT06238622
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment	idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder	Active, not recruiting	Phase 2	2026-09-25		NCT07036523
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis	idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder	Recruiting	Phase 2	2026-09-04		NCT06968845
Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF	idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder	Active, not recruiting	Phase 2	2026-07-16		NCT05389215
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)	interstitial lung disease, lung disorder, respiratory system disorder	Recruiting	Phase 3	2026-07-13		NCT05943535